RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune therapy trial targets Tough-to-Treat leukemia
Disease control OngoingThis is an early-stage safety study testing a new type of personalized immune cell therapy called BAFFR-CAR T cells in adults with B-cell acute lymphoblastic leukemia that has come back or stopped responding to standard treatments. The main goals are to find a safe dose and under…
Matched conditions: RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: PeproMene Bio, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Personalized immune cell therapy tested as potential lifeline for Tough-to-Treat adult leukemia
Disease control OngoingThis study is testing a personalized cell therapy called AUTO1 for adults with a type of blood cancer (B-cell ALL) that has come back or hasn't responded to other treatments. Doctors take a patient's own immune cells, modify them in a lab to better target cancer cells, and then i…
Matched conditions: RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC